美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Therapix Biosciences Ltd.

0.3170

0.0000

成交量：- -

成交額：- -

市值：181.31萬

市盈率：-0.11

高：0.3170

開：0.3170

低：0.3170

收：0.3170

52周最高：4.69

52周最低：0.2522

股本：571.97萬

流通股本：557.84萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-2.7977

每股收益(LYR):-170.1534

淨資產收益率：-9843.96%

總資產收益率：-89.87%

市淨率：129.51

市盈率(LYR):0.00

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Therapix Biosciences Ltd.

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://therapixbio.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Therapix Biosciences Ltd.是一個專業的製藥公司，於2004年8月23日成立於以色列並開始運營。它專註於創建和增強基於大麻素藥物的技術和資產組合。有了這個重點，公司啟動了兩個內部藥物開發計劃，基於再利用FDA批準的合成大麻素（dronabinol）：聯合Pharma開發THX-TS01針對Tourette綜合征或TS的治療和聯合BrainBright開發THX-ULD01針對輕度認知障礙或MCI的高價值和服務不足的市場。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/TRPX/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TRPX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRPX\",,,,,undefined,":{"symbol":"TRPX","market":"US","secType":"STK","nameCN":"Therapix Biosciences Ltd.","latestPrice":0.317,"timestamp":1593633600000,"preClose":0.317,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":5578438,"shares":5719700,"eps":-2.797749,"marketStatus":"退市","change":0,"latestTime":"07-01 16:00:00 EDT","open":0.317,"high":0.317,"low":0.317,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.797749,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774339200000},"marketStatusCode":5,"adr":0,"adrRate":40,"listingDate":1490155200000,"exchange":"NASDAQ","adjPreClose":0.317,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRPX\",,,,,undefined,":{"symbol":"TRPX","floatShares":5578438,"roa":"-89.87%","roe":"-9843.96%","lyrEps":-170.15344,"shares":5719700,"dividePrice":0,"high":0.317,"amplitude":0,"preClose":0.317,"low":0.317,"week52Low":0.2522,"pbRate":"129.51","week52High":4.69,"institutionHeld":0,"latestPrice":0.317,"eps":-2.797749,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.797749,"open":0.317},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRPX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-10-19","symbol":"TRPX","defaultRemindTime":1603114200000,"type":"split","dateTimestamp":1603080000000,"forFactor":10000000,"toFactor":142857,"ratio":70.00007},{"market":"US","date":"2019-05-15","symbol":"TRPX","fiscalQuarterEnding":"2018/12","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1557892800000,"reportTimeType":"","actualEps":-0.83},{"market":"US","date":"2018-12-03","symbol":"TRPX","fiscalQuarterEnding":"2018/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1543813200000,"reportTimeType":"","actualEps":-0.5},{"market":"US","date":"2018-08-20","symbol":"TRPX","fiscalQuarterEnding":"2018/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1534737600000,"reportTimeType":"","actualEps":-0.35},{"market":"US","date":"2018-05-31","symbol":"TRPX","fiscalQuarterEnding":"2018/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1527739200000,"reportTimeType":"","actualEps":0.59}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRPX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRPX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://therapixbio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Therapix Biosciences Ltd.是一個專業的製藥公司，於2004年8月23日成立於以色列並開始運營。它專註於創建和增強基於大麻素藥物的技術和資產組合。有了這個重點，公司啟動了兩個內部藥物開發計劃，基於再利用FDA批準的合成大麻素（dronabinol）：聯合Pharma開發THX-TS01針對Tourette綜合征或TS的治療和聯合BrainBright開發THX-ULD01針對輕度認知障礙或MCI的高價值和服務不足的市場。","exchange":"NASDAQ","name":"Therapix Biosciences Ltd.","nameEN":"Therapix Biosciences Ltd."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"TRPX\",market:\"US\",,,undefined,":null}}